.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
orchid pharma faces liquidation as lenders reject resolution plan
.
it would likely look like what occurred in minnesota last year, when a
.